Body composition assessment (ie, the measurement of muscle and adiposity) impacts
several cancer-related outcomes including treatment-related toxicities, treatment responses …

The majority of cancer patients experience some form of body composition change during
the disease trajectory. For example, breast cancer patients undergoing chemotherapy and …

There is growing interest from the oncology community to understand how body composition
measures can be used to improve the delivery of clinical care for the 18.1 million individuals …

In recent years, there has been increasing interest in the influence of body composition on
oncological patient outcomes. Visceral obesity, sarcopenia and sarcopenic obesity have …

Background Computed tomography images acquired during routine cancer care provide an
opportunity to determine body composition with accuracy and precision. Quantification of …

Advancements in image-based technologies and body composition research over the past
decade has led to increased understanding of the importance of muscle abnormalities, such …

Human body composition is important in numerous cancer research domains. Our objective
was to evaluate clinically accessible methods to achieve practical and precise measures of …

Background Body composition from computed tomography (CT) scans is associated with
cancer outcomes including surgical complications, chemotoxicity, and survival. Most studies …

Loss of lean body develops from an imbalance in protein synthesis and catabolism and is
associated with a variety of different disease and nondisease states, including severe …

Sarcopenia (severe skeletal muscle wasting) and sarcopenic obesity (skeletal muscle
wasting in the setting of excess fat) have been increasingly recognized as important …